Related Experiment Video
Updated: Aug 29, 2025

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
The Evolving Scenario of COVID-19 in Hemodialysis Patients
Pasquale Esposito1,2, Daniela Picciotto2, Francesca Cappadona1,2
1Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy.
Insights
COVID-19 outcomes significantly improved in hemodialysis patients post-vaccination. Vaccination reduced asymptomatic cases, fever, and pulmonary involvement, leading to shorter illness duration and lower mortality rates.
Area of Science:
- Nephrology
- Infectious Diseases
- Immunology
Background:
- Coronavirus disease 2019 (COVID-19) is a dynamic illness impacting patient populations differently.
- Hemodialysis patients represent a vulnerable group with potentially altered COVID-19 trajectories.
- The advent of vaccination campaigns necessitates evaluating the evolving impact of COVID-19 in this cohort.
Purpose of the Study:
- To compare the clinical presentation and outcomes of COVID-19 in hemodialysis patients before and after widespread vaccination.
- To assess the influence of vaccination status on COVID-19 severity and progression in hemodialysis patients.
Main Methods:
- Retrospective cohort study comparing two groups of hemodialysis patients with COVID-19.
- Group 1: March-December 2020 (pre-vaccination/early pandemic).
- Group 2: September 2021-February 2022 (post-vaccination).
Main Results:
- Vaccinated patients (Group 2) exhibited more asymptomatic cases (38% vs. 10%) and less fever/pulmonary involvement compared to Group 1.
- Group 2 showed higher lymphocyte counts, lower IL-6 levels, faster inflammatory marker improvement, and reduced hospitalization (12.7% vs. 38%).
- Illness duration (18.8 vs. 29.2 days) and mortality rates (5.4% vs. 25%) were significantly lower in Group 2.
Conclusions:
- COVID-19 presentation and course have demonstrably improved in hemodialysis patients following vaccine implementation.
- Vaccination is associated with milder disease, reduced complications, and improved survival in this vulnerable population.
- Continued active surveillance remains crucial due to the evolving nature of COVID-19 variants and disease dynamics.
Abstract:
Coronavirus disease 2019 (COVID-19) is a rapidly changing disease. Therefore, in this study, to evaluate the evolution of COVID-19 in hemodialysis patients, we retrospectively compared patients affected by COVID-19 during the first pandemic waves of 2020 (from March to December 2020-Group 1) with patients with COVID-19 from September 2021 to February 2022 (Group 2) after the full completion of vaccination. Group 1 was constituted of 44 patients (69.3 ± 14.6 years), and Group 2 of 55 patients (67.4 ± 15.3 years). Among Group 2, 52 patients (95%) were vaccinated. Patients of Group 2, compared with Group 1, were more often asymptomatic (38 vs. 10%, p = 0.002) and reported less frequent fever and pulmonary involvement. At diagnosis, Group 2 showed a significantly higher number of lymphocytes and lower levels of circulating IL-6 (16 ± 13.3 vs. 41 ± 39.4 pg/mL, p = 0.002). Moreover, in Group 2, inflammatory parameters significantly improved after a few days from diagnosis. Patients of Group 2 presented a lower hospitalization rate (12.7 vs. 38%, p = 0.004), illness duration (18.8 ± 7.7 vs. 29.2 ± 19.5 days, p = 0.005), and mortality rate (5.4 vs. 25%, p = 0.008). Finally, responders to the vaccination (80% of vaccinated patients) compared with nonresponders showed a reduction in infection duration and hospitalization (5 vs. 40%, p = 0.018). In conclusion, we found that COVID-19 presentation and course in hemodialysis patients have improved over time after the implementation of vaccine campaigns. However, due to the evolving nature of the disease, active surveillance is necessary.
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care

